Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-04

Clinical Trial Update: Ovarian Hyperstimulation Syndrome and Cabergoline [NA]

View source ↗

Summary

This clinical trial update reports on a completed study evaluating cabergoline for ovarian hyperstimulation syndrome, including subjects with polycystic ovary s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CABERGOLINE (CABERGOLINE)

Snippet

Sponsor: Etlik Zubeyde Hanim Womens' Health and Teaching Hospital | Conditions: Polycystic Ovarian Syndrome, Ovarian Hyperstimulation Syndrome | NA | Status: COMPLETED